KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacira BioSciences (PCRX) EPS (Weighted Average and Diluted): 2011-2024

Historic EPS (Weighted Average and Diluted) for Pacira BioSciences (PCRX) over the last 13 years, with Dec 2024 value amounting to -$2.15.

  • Pacira BioSciences' EPS (Weighted Average and Diluted) rose 103.86% to $0.12 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.46, marking a year-over-year increase of 122.89%. This contributed to the annual value of -$2.15 for FY2024, which is 341.57% down from last year.
  • Per Pacira BioSciences' latest filing, its EPS (Weighted Average and Diluted) stood at -$2.15 for FY2024, which was down 341.57% from $0.89 recorded in FY2023.
  • Pacira BioSciences' 5-year EPS (Weighted Average and Diluted) high stood at $3.33 for FY2020, and its period low was -$2.15 during FY2024.
  • Its 3-year average for EPS (Weighted Average and Diluted) is -$0.31, with a median of $0.34 in 2022.
  • As far as peak fluctuations go, Pacira BioSciences' EPS (Weighted Average and Diluted) surged by 1,333.33% in 2020, and later plummeted by 341.57% in 2024.
  • Yearly analysis of 5 years shows Pacira BioSciences' EPS (Weighted Average and Diluted) stood at $3.33 in 2020, then tumbled by 72.37% to $0.92 in 2021, then crashed by 63.04% to $0.34 in 2022, then soared by 161.76% to $0.89 in 2023, then tumbled by 341.57% to -$2.15 in 2024.